Berenberg Bank initiated coverage on shares of Medical Properties Trust (NYSE:MPW) in a research note issued to investors on Thursday morning, The Fly reports. The firm issued a buy rating and a $22.00 target price on the real estate investment trust’s stock.

Other research analysts also recently issued research reports about the stock. Barclays initiated coverage on shares of Medical Properties Trust in a research note on Tuesday, September 3rd. They issued an overweight rating and a $20.00 price target on the stock. SunTrust Banks raised their price target on shares of Medical Properties Trust from $20.00 to $21.00 and gave the stock a buy rating in a research note on Tuesday, August 27th. Deutsche Bank raised shares of Medical Properties Trust from a hold rating to a buy rating in a research note on Monday, July 29th. Zacks Investment Research downgraded shares of Medical Properties Trust from a hold rating to a sell rating in a research note on Wednesday, July 17th. Finally, ValuEngine downgraded shares of Medical Properties Trust from a buy rating to a hold rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. Medical Properties Trust presently has a consensus rating of Buy and an average target price of $19.59.

Shares of Medical Properties Trust stock traded down $0.48 during trading on Thursday, hitting $18.46. The stock had a trading volume of 4,515,346 shares, compared to its average volume of 3,801,662. The firm’s fifty day simple moving average is $18.24 and its 200-day simple moving average is $18.15. The stock has a market cap of $8.51 billion, a PE ratio of 13.47, a PEG ratio of 3.63 and a beta of 0.56. The company has a debt-to-equity ratio of 0.99, a current ratio of 8.00 and a quick ratio of 8.00. Medical Properties Trust has a 12 month low of $13.98 and a 12 month high of $19.26.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.31. The firm had revenue of $192.55 million during the quarter, compared to analyst estimates of $186.11 million. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. The business’s revenue was down 4.6% on a year-over-year basis. During the same quarter last year, the business earned $0.36 EPS. Analysts expect that Medical Properties Trust will post 1.3 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Thursday, September 12th will be given a dividend of $0.26 per share. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Wednesday, September 11th. This represents a $1.04 dividend on an annualized basis and a yield of 5.63%. Medical Properties Trust’s dividend payout ratio (DPR) is 75.91%.

In other Medical Properties Trust news, insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the transaction, the insider now owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director G Steven Dawson acquired 7,476 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was purchased at an average cost of $18.07 per share, for a total transaction of $135,091.32. Following the transaction, the director now owns 76,302 shares in the company, valued at $1,378,777.14. The disclosure for this purchase can be found here. Company insiders own 1.18% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Cullen Frost Bankers Inc. boosted its stake in Medical Properties Trust by 70.9% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 760 shares in the last quarter. Manchester Financial Inc. acquired a new stake in Medical Properties Trust in the 2nd quarter worth approximately $33,000. Cascade Investment Advisors Inc. acquired a new stake in Medical Properties Trust in the 2nd quarter worth approximately $35,000. Princeton Global Asset Management LLC acquired a new stake in Medical Properties Trust in the 1st quarter worth approximately $37,000. Finally, Icon Wealth Partners LLC acquired a new stake in Medical Properties Trust in the 1st quarter worth approximately $42,000. 71.37% of the stock is currently owned by hedge funds and other institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: What is the Moving Average Convergence Divergence (MACD) oscillator?

The Fly

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.